1 / 12

Neuralgia Treatment Market

The neuralgia treatment market is expected to witness significant growth owing to the increasing incidences of diabetes and trigeminal neuralgia. Furthermore, multiple sclerosis is also one of factors which can cause neuralgia. Multiple sclerosis decreases the body immunity owing to the neurodegenerative condition which affects the myelin sheath that can cause neuralgia. This is likely to drive market demand over the forecast period.

Ronald15
Télécharger la présentation

Neuralgia Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neuralgia Treatment Market Market Size Worth $2.83 billion By 2027 | CAGR: 6.1%

  2. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% “As per Polaris Market Research report, Neuralgia Treatment Market is attending major innovations & transformations and is projected to reach $2.83 billion By 2027 | CAGR: 6.1% during the conjecture period 2020 to 2027.” The global Neuralgia Treatment Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Neuralgia Treatment Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2027. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Neuralgia Treatment Market Report Scope: The global Neuralgia Treatment Market is segmented ByTreatment, By End-Use, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Neuralgia Treatment Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Neuralgia Treatment Market growth during the forecast period from 2020-2027. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% By Treatment By End-Use By Region •Drug Based •Hospitals & Clinics •North America (U.S., Canada) • •Ambulatory Surgery •Europe (France, Germany, UK, Italy, Spain, Anticonvulsant Medicines o Carbamazepine o Oxcarbazepine o Topiramate o Gabapentin o Pregabalin o Clonazepam o Phenytoin o Lamotrigine o Valproic Acid Centers Netherlands, Austria) •Others •Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) • Tricyclic Antidepressants o Amitriptyline o Nortriptyline •Surgeries • Balloon Compression • Glycerol Injection • Radiofrequency Thermal Lesioning • Stereotactic Radiosurgery •Microvascular Decompression ➢COVID-19 Impact Analysis for Neuralgia Treatment Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Neuralgia Treatment Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Neuralgia Treatment Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook - 3 -

  4. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Neuralgia Treatment Market Analysis: https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market ➢Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Neuralgia Treatment Market include Allergan Plc, GlaxoSmithKline Plc., Biogen, Inc., Abbott Laboratories, PixarBio Corporation, Merz Pharma GmbH, Trigemina Inc., Pfizer Inc., Novartis, Lupin https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment- Request for sample: market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining - 4 -

  5. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Neuralgia Treatment Market Insights 4.1.Neuralgia Treatment – Industry snapshot 4.2.Neuralgia Treatment Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. High incidence rate of Neuralgia 4.2.1.2. Sports injuries causing neuro-degenrative disorders 4.2.2.Restraints and Challenges 4.2.2.1. High cost of treatment 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Neuralgia Treatment Market Industry trends 5.Neuralgia Treatment Market Assessment by Treatment 5.1.Key Findings 5.2.Introduction 5.2.1.Global Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 5.3.Drug Based 5.3.1.Global Neuralgia Treatment Market, by Drug Based, by Region, 2016 – 2027 (USD Million) 5.3.2.Anticonvulsant Medicines 5.3.2.1. Anticonvulsant Medicines Market, by Region, 2016 – 2027 (USD Million) 5.3.2.2. Carbamazepine 5.3.2.2.1. Carbamazepine Market, by Region, 2016 – 2027 (USD Million) 5.3.2.3. Oxcarbazepine 5.3.2.3.1. Oxcarbazepine Market, by Region, 2016 – 2027 (USD Million) 5.3.2.4. Topiramate 5.3.2.4.1. Topiramate Market, by Region, 2016 – 2027 (USD Million) 5.3.2.5. Gabapentin 5.3.2.5.1. Gabapentin Market, by Region, 2016 – 2027 (USD Million) 5.3.2.6. Pregabalin - 5 -

  6. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 5.3.2.6.1. 5.3.2.7. 5.3.2.7.1. 5.3.2.8. 5.3.2.8.1. 5.3.2.9. 5.3.2.9.1. 5.3.2.10.Valproic Acid 5.3.2.10.1. 5.3.3.Tricyclic Antidepressants 5.3.3.1. Tricyclic Antidepressants Market, by Region, 2016 – 2027 (USD Million) 5.3.3.2. Amitriptyline 5.3.3.2.1. Amitriptyline Market, by Region, 2016 – 2027 (USD Million) 5.3.3.3. Nortriptyline 5.3.3.3.1. Nortriptyline Market, by Region, 2016 – 2027 (USD Million) 5.4.Surgery 5.4.1.Global Neuralgia Treatment Market, by Surgery, by Region, 2016 – 2027 (USD Million) 5.4.2.Balloon Compression 5.4.2.1. Balloon Compression Market, by Region, 2016 – 2027 (USD Million) 5.4.3.Glycerol Injection 5.4.3.1. Glycerol Injection Market, by Region, 2016 – 2027 (USD Million) 5.4.4.Radiofrequency Thermal Lesioning 5.4.4.1. Radiofrequency Thermal Lesioning Market, by Region, 2016 – 2027 (USD Million) 5.4.5.Stereotactic Radiosurgery 5.4.5.1. Stereotactic Radiosurgery Market, by Region, 2016 – 2027 (USD Million) 5.4.6.Microvascular Decompression 5.4.6.1. Microvascular Decompression Market, by Region, 2016 – 2027 (USD Million) 6.Global Neuralgia Treatment Market, by End Use 6.1.Key Findings 6.2.Introduction 6.2.1.Global Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 6.3.Hospital & Clinics 6.3.1.Global Neuralgia Treatment Market, by Hospital & Clinics, By Region, 2016 – 2027 (USD Million) Pregabalin Market, by Region, 2016 – 2027 (USD Million) Clonazepam Clonazepam Market, by Region, 2016 – 2027 (USD Million) Phenytoin Phenytoin Market, by Region, 2016 – 2027 (USD Million) Lamotrigine Lamotrigine Market, by Region, 2016 – 2027 (USD Million) Valproic Acid Market, by Region, 2016 – 2027 (USD Million) - 6 -

  7. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 6.4.Ambulatory Surgery Centers 6.4.1.Global Neuralgia Treatment Market, by Ambulatory Surgery Centers, by Region, 2016 – 2027 (USD Million) 6.5.Others 6.5.1.Global Neuralgia Treatment Market, by Others, by Region, 2016 – 2027 (USD Million) 7.Neuralgia Treatment Market Assessment by Geography 7.1.Key findings 7.2.Introduction 7.2.1.Neuralgia Treatment Market Assessment, By Geography, 2016 – 2027 (USD Million) 7.3.Neuralgia Treatment Market – North America 7.3.1.North America: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.3.2.North America: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.3.3.Neuralgia Treatment Market – U.S. 7.3.3.1. U.S.: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.3.3.2. U.S.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.3.4.Neuralgia Treatment Market – Canada 7.3.4.1. Canada: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.3.4.2. Canada.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.Neuralgia Treatment Market – Europe 7.4.1.Europe: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.2.Europe: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.3.Neuralgia Treatment Market – UK 7.4.3.1. UK: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.3.2. UK: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.4.Neuralgia Treatment Market – France 7.4.4.1. France: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.4.2. France: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.5.Neuralgia Treatment Market – Germany 7.4.5.1. Germany: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) - 7 -

  8. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 7.4.5.2. Germany: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.6.Neuralgia Treatment Market – Italy 7.4.6.1. Italy: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.6.2. Italy: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.7.Neuralgia Treatment Market – Spain 7.4.7.1. Spain: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.7.2. Spain: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.8.Neuralgia Treatment Market – Netherlands 7.4.8.1. Netherlands: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.8.2. Netherlands: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.9.Neuralgia Treatment Market – Austria 7.4.9.1. Austria: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.9.2. Austria: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.Neuralgia Treatment Market – Asia-Pacific 7.5.1.Asia Pacific: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.2.Asia Pacific: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.3.Neuralgia Treatment Market – China 7.5.3.1. China: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.3.2. China: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.4.Neuralgia Treatment Market – India 7.5.4.1. India: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.4.2. India.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.5.Neuralgia Treatment Market – Malaysia 7.5.5.1. Malaysia: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.5.2. Malaysia: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.6.Neuralgia Treatment Market – Japan - 8 -

  9. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 7.5.6.1. Japan: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.6.2. Japan: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.7.Neuralgia Treatment Market – Indonesia 7.5.7.1. Indonesia: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.7.2. Indonesia: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.8.Neuralgia Treatment Market – South Korea 7.5.8.1. South Korea: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.8.2. South Korea.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.Neuralgia Treatment Market – Middle East & Africa 7.6.1.Middle East & Africa: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.2.Middle East & Africa.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.3.Neuralgia Treatment Market – Saudi Arabia 7.6.3.1. Saudi Arabia: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.3.2. Saudi Arabia.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.4.Neuralgia Treatment Market – UAE 7.6.4.1. UAE: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.4.2. UAE: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.5.Neuralgia Treatment Market – Israel 7.6.5.1. Israel: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.5.2. Israel: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.6.Neuralgia Treatment Market – South Africa 7.6.6.1. South Africa: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.6.2. South Africa: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.Neuralgia Treatment Market – Latin America 7.7.1.Latin America: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) - 9 -

  10. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 7.7.2.Latin America: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.3.Neuralgia Treatment Market – Mexico 7.7.3.1. Mexico: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.7.3.2. Mexico.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.4.Neuralgia Treatment Market – Brazil 7.7.4.1. Brazil: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.7.4.2. Brazil.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.5.Neuralgia Treatment Market – Argentina 7.7.5.1. Argentina: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.7.5.2. Argentina.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 8.Competitive Landscape 8.1.Expansion and Acquisition Analysis 8.1.1.Expansion 8.1.2.Acquisitions 8.2.Partnerships/Collaborations/Agreements/Exhibitions 9.Company Profiles 9.1.Allergan Plc 9.1.1.Company Overview 9.1.2.Financial Performance 9.1.3.Product Benchmarking 9.1.4.Recent Development 9.2.Merz Pharma GmbH & Co. 9.2.1.Company Overview 9.2.2.Financial Performance 9.2.3.Product Benchmarking 9.2.4.Recent Development 9.3.Abbott Laboratories 9.3.1.Company Overview 9.3.2.Financial Performance 9.3.3.Product Benchmarking 9.3.4.Recent Development 9.4.Trigemina Inc. 9.4.1.Company Overview - 10 -

  11. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% 9.4.2.Financial Performance 9.4.3.Product Benchmarking 9.4.4.Recent Development 9.5.Pfizer Inc. 9.5.1.Company Overview 9.5.2.Financial Performance 9.5.3.Product Benchmarking 9.5.4.Recent Development 9.6.Novartis 9.6.1.Company Overview 9.6.2.Financial Performance 9.6.3.Product Benchmarking 9.6.4.Recent Development 9.7.GlaxoSmithKline Plc. 9.7.1.Company Overview 9.7.2.Financial Performance 9.7.3.Product Benchmarking 9.7.4.Recent Development 9.8.Lupin 9.8.1.Company Overview 9.8.2.Financial Performance 9.8.3.Product Benchmarking 9.8.4.Recent Development 9.9.Cadila Healthcare Limited 9.9.1.Company Overview 9.9.2.Financial Performance 9.9.3.Product Benchmarking 9.9.4.Recent Development 9.10. Lundbeck Pharmaceuticals LLC 9.10.1.Company Overview 9.10.2.Financial Performance 9.10.3.Product Benchmarking 9.10.4.Recent Development 9.11. Biogen 9.11.1.Company Overview 9.11.2.Financial Performance 9.11.3.Product Benchmarking 9.11.4.Recent Development ➢Access Press Release on Neuralgia Treatment Market: https://www.polarismarketresearch.com/press-releases/neuralgia-treatment-market ➢About Polaris Market Research - 11 -

  12. Neuralgia Treatment Market Size Worth $2.83 billion By 2027 | CAGR: 6.1% Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 12 -

More Related